Please select the option that best describes you:
Topics:
Hematologic Malignancies • Medical Oncology • Lymphoma • NCI-CCC Tumor Board Question • Internal Medicine • Hematology • NCI-CCC Lymphoma Tumor Board Question • City of Hope
How would you manage a patient with p53 mutated MCL who has progressed after a BTKi and CAR-T with a CD20 negative clone?
Answer from: Medical Oncologist at Community Practice
Venetoclax + CD19 or CD22 mab if available
Sign in or Register to read more